NEW HAVEN, Conn., Oct. 27, 2008 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals today announced the presentation of data from its antibacterial and HIV programs at the 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/ Infectious Diseases Society of America (IDSA) 46th annual meeting, held October 25-28, 2008, in Washington, D.C.
